# Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

> **NCT03551067** · PHASE4 · COMPLETED · sponsor: **Suez Canal University** · enrollment: 74 (actual)

## Conditions studied

- Adenotonsillectomy

## Interventions

- **DRUG:** Dexmedetomidine
- **COMBINATION_PRODUCT:** Midazolam/Ketamine

## Key facts

- **NCT ID:** NCT03551067
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-01
- **Primary completion:** 2017-12-15
- **Final completion:** 2018-01-05
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551067, "Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03551067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*